logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

Cv Therapeutics, Inc.


USPTO Granted Patents = 105



Trademarks = 5

Forward Citations = 1,503

Loading Chart...
Loading Chart...

71 inventors (with patents filed for the assignee):

goldMedal Jeff A Zablocki (63 out of 157 patents)

silverMedal Elfatih O Elzein (46 out of 87 patents)

bronzeMedal Venkata Poornapragnacharyulu Palle (37 out of 104 patents)

4.  Prabha N Ibrahim (27 out of 134 patents)

5.  Xiaofen Li (14 out of 40 patents)

6.  Vaibhav Varkhedkar (13 out of 19 patents)

7.  Rao V Kalla (11 out of 53 patents)

8.  Thao Perry (10 out of 47 patents)

9.  Andrew A Wolff (10 out of 18 patents)

10.  Brent K Blackburn (10 out of 14 patents)

11.  Kevin D Shenk (9 out of 27 patents)

12.  Tim Marquart (9 out of 9 patents)

13.  Steven R Schow (8 out of 28 patents)

14.  Luiz Belardinelli (8 out of 41 patents)

15.  Robert T Lum (8 out of 25 patents)


Core Competencies:
Tinea Pedis Treatment
Myocardial Perfusion Imaging
C-Pyrazole A2A Receptor Agonists
Arrhythmia Treatment
Substituted Heterocyclic Compounds
ABCA1 Elevating Compounds
Polymer Coating Medical Devices
A1 Adenosine Receptor Agonists
Cholesterol Efflux
Purine Inhibitors
Cholesterol Esterase Inhibition

105 patents:

1. 12186285 - Compositions and methods of treatment for tinea pedis (2025-01-07),
2. 7713946 - [object Object] (2010-05-11),
3. 7696181 - [object Object] (2010-04-13),
4. 7582617 - Myocardial perfusion imaging method (2009-09-01),
5. 7553823 - C-pyrazole A2A receptor agonists (2009-06-30),
6. 7521554 - [object Object] (2009-04-21),
7. 7517888 - [object Object] (2009-04-14),
8. 7514417 - [object Object] (2009-04-07),
9. 7488720 - [object Object] (2009-02-10),
10. 7479485 - Method of treating arrhythmias (2009-01-20),
11. 7452889 - Substituted heterocyclic compounds (2008-11-18),
12. 7449473 - [object Object] (2008-11-11),
13. 7432276 - ABCA1 elevating compounds (2008-10-07),
14. 7423045 - ABCA1 elevating compounds (2008-09-09),
15. 7419709 - Polymer coating for medical devices (2008-09-02),
CV Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule drugs for the treatment of cardiovascular diseases. With a strong focus on innovative cardiovascular therapies, the company aims to improve patient outcomes and address unmet medical needs in this field. CV Therapeutics has a diverse pipeline of drug candidates targeting various cardiovascular conditions, such as heart failure, angina, and arrhythmias.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

105 Patents

#6 in Foster City, CA

#809 in California

#3,488 in US

#7,248 in the World

...
Foster City, CA, United States of America

Cv Therapeutics, Inc.

Forward Citations = 1,503

71 inventors:

goldMedal Jeff A Zablocki (63 out of 157 patents)

silverMedal Elfatih O Elzein (46 out of 87 patents)

bronzeMedal Venkata Poornapragnacharyulu Palle (37 out of 104 patents)

4.  Prabha N Ibrahim (27 out of 134 patents)

5.  Xiaofen Li (14 out of 40 patents)

Please report any incorrect information to support@idiyas.com
Loading…